ArticleJBMR plus2026
11β-Hydroxysteroid dehydrogenase type 1 deficiency causes sexual dimorphism in body composition and bone mass in response to caloric restriction.
Article in JBMR plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Caloric restriction (CR) alters energy metabolism and increases systemic glucocorticoid production, contributing to bone loss and bone marrow adipose tissue (BMAT) expansion. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) mediates the local amplification of glucocorticoids within these tissues, but its contribution to CR-induced skeletal alterations remains unclear. Eight-week-old male and female WT and global 11β-HSD1 KO mice were assigned to ad libitum feeding or 30% CR for 8 wk. Body composition was assessed by DXA, bone microarchitecture by micro-CT (μCT), biomechanics by 3-point bending, BMAT by histology, serum bone turnover markers, and corticosterone by ELISA. Caloric restriction reduced body weight and lean mass of both sexes and genotypes. Fat mass was decreased in males WT and KO but not in females, while bone mass was reduced significantly in WT and KO female CR. Micro-CT revealed trabecular and cortical deterioration in both WT and KO CR females. Bone marrow adipose tissue was increased in mice under CR in both sexes, regardless of genotype. KO mice exhibited elevated corticosterone during CR, suggesting compensatory hypothalamic-pituitary-adrenal activation. These results demonstrate that CR induces sex-dependent changes in mesenchymal tissues. Under CR, females preserved fat mass but lost bone mass, while males maintained bone mass despite fat loss. Both sexes experienced lean mass loss. The effects of 11β-HSD1 deletion were also sex-specific: female KO mice had higher trabecular and cortical parameters, and lean mass under ad libitum feeding, while male KO mice under CR showed increased lean mass and trabecular bone thickness. However, 11β-HSD1 deletion did not prevent BMAT expansion in either sex under CR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.